Aptinyx Inc. (APTX)
Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program. The company was founded by Norbert G. Riedel and Joseph R. Moskal in June 2015 and is headquartered in Evanston, IL.
Address
1801 MAPLE AVENUE
EVANSTON, IL 60201
Founded
2015
Number of Employees
12
Website
http://www.aptinyx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)